News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
Selecting the most appropriate clinical trial design is of utmost importance, and it can be the difference between...
[Sofia, Bulgaria] – Comac Medical proudly welcomes Brian Swindley as our new Global Head of Project Management. Brian...
This May, Comac Medical proudly celebrates the 20th anniversary of our North Macedonia office. Originally established with headquarters...